Human papillomavirus infection in progressive and non-progressive cervical intraepithelial neoplasia

APMIS

Volumn 104, Issue 12, 1996, Pages 900-906

  Bertelsen, Bjørn ^a,b   Kalvenes, May Britt ^a   Hartveit, Flora ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

cervical intraepithelial neoplasia; human papillomavirus; in situ hybridization; polymerase chain reaction

Indexed keywords

COCARCINOGEN;

ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; VIRUS CARCINOGENESIS; WART VIRUS;

EID: 0030499829     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1996.tb04956.x     Document Type: Article

References (31)

1. Altman, D. G.: Practical statistics for medical research. Chapman & Hall, London 1991, pp. 258-259.
2. Bertelsen, B. & Hartveit, F.: The cervical smear record: Its relevance to the subsequent development of cervical neoplasia. Acta Obstet. Gynecol. Scand. 74: 729-733, 1995.
3. Bertelsen, B. & Hartveit, F.: The differences in the cytological histories of women with high- and low-grade cervical intraepithelial neoplasia. Eur. J. Gynaecol. Oncol. XVII: 183-187, 1996.
4. Bjorge, T., Skare, G. B., Slåttekjær, P. E., Melby, W., Olsen, M. & Thoresen, S. Ø.: Masseundersøkelsen mot livmorhalskreft. Evaluering av prøveprosjektet. (In Norwegian). Kreftregisteret, Oslo 1994.
5. Bodén, E., Evander, M., Wadell, G. R., Bjersing, L., von Schoultz, B. & Rylander, E.: Detection of human papilloma virus in women referred for colposcopy. Acta Obstet. Gynecol. Scand. 69: 153-159, 1990.
6. Burger, M. P. M., Hollema, H., Gouw, A. S. H., Pieters, W. J. L. M. & Quint, W. G. V.: Cigarette smoking and human papillomavirus in patients with reported cervical cytological abnormality. BMJ 306: 149-152, 1993.
7. Campion, M. J., Cuzick, J., McCance, D. J. & Singer, A.: Progressive potential of mild cervical atypia: Prospective cytological, colposcopic, and virological study. Lancet ii: 237-240, 1986.
8. Coleman, D., Day, N., Douglas, G., Farmery, E., Lynge, E., Philip, J. & Segnan, N.: European guidelines for quality assurance in cervical cancer screening. Eur. J. Cancer 29A, 4 (Suppl.): S1-S38, 1993.
9. Coleman, D. V. & Evans, D. M. D.: Biopsy pathology and cytology of the cervix. Chapman and Hall Medical, London 1988, pp. 113-122.
10. Crum, C. P. & Nuovo, G. J.: Latent or occult HPV infection. In: Crum, C. P. & Nuovo, G. J. (Eds.): Genital papillomaviruses and related neoplasms. Raven Press Ltd. 1991, pp. 88-105.
11. de Roda Husman, A.-M., Walboomers, J. M. M., van den Brule, A. J. C., Meijer, C. J. L. M. & Snijders, P. J. F.: The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J. Gen. Virol. 76: 1057-1062, 1995.
12. Herrington, C. S., Anderson, S. M., Bauer, H. M., Troneone, G., de Angelis, M. L., Noell, H., Chimera, J. A., Van Eyck, S. L. & McGee, J. O'D.: Comparative analysis of human papillomavirus detection by PCR and non-isotopic in situ hybridisation. J. Clin. Pathol. 48: 415-419, 1995.
13. Hirschowitz, L., Raffle, A. E., Mackenzie, E. F. D. & Hughes, A. O.: Long term follow up of women with borderline cervical smear test results: effects of age and viral infection on progression to high grade dyskaryosis. BMJ 304: 1209-1212, 1992.
14. IARC monographs on the evaluation of carcinogenic risks to humans, human papillomaviruses. IARC, World Health Organization, Lyon 64: 281-282, 1995.
15. Kirby, A. J., Spiegelhalter D. J., Day, N. E., Fenton, L. S. K., Mann, E. M. F. & Macgregor, J. E.: Conservative treatment of mild/moderate cervical dyskaryosis: long-term outcome. Lancet 339: 828-831, 1992.
16. Kiviat, N. B., Critchlow, C. W. & Kurman, R. J.: Reassessment of the morphological continuum of cervical intraepithelial lesions: does it reflect different stages in the progression to cervical carcinoma? IARC Sci. Publ. 119: 59-66, 1992.
17. Kiviat, N. B., Koutsky, L. A., Paavonen, J. A., Galloway, D. A., Critchlow, C. W., Beckmann, A. M., McDougall, J. K., Peterson, M. L. Stevens, C. E., Lipinski, C. M. & Holmes, K. K.: Prevalence of genital papillomavirus infection among women attending a college student health clinic or a sexually transmitted disease clinic. J. Infect. Dis. 159: 293-302, 1989.
18. Kwok, S.: Procedures to minimize PCR-product carry-over. In: Innis, M. A., Gelfand, D. H., Sninsky, J. J. J. & White, T. J. (Eds.): PCR Protocols. Academic Press, Inc. 1990, pp. 142-145.
19. Munoz, N., Bosch, F. X., de Sanjose, S., Tafur, L., Izarzugaza, I., Gili, M., Viladiu, P., Navarro, C., Martos, C., Ascunce, N., Gonzales, L. C., Kaldor, J. M., Guerrero, E., Lorinez, A., Santamaria, M., Alonso de Ruiz, P., Aristizabal, N. & Shah, K.: The causal link between human papillomavirus and invasive cervical cancer: A population-based case-control study in Colombia and Spain. Int. J. Cancer 52: 743-749, 1992.
20. Nasiell, K., Nasiell, M. & Vaclavinkova, V.: Behavior of moderate cervical dysplasia during long-term follow-up. Obstet. Gynecol. 61: 609-614, 1983.
21. Nasiell, K., Roger, V. & Nasiell, M.: Behavior of mild cervical dysplasia during long-term follow-up. Obstet. Gynecol. 67: 665-669, 1986.
22. Remmink, A. J., Walboomers, J. M. M., Helmerhorst, T. J. M., Voorhorst, F. J., Rozendaal, L., Risse, E. K. J., Meijer, C. J. L. M. & Kenemans, P.: The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months. Int. J. Cancer 61: 306-311, 1995.
23. Richart, R. M. & Barron, B. A.: Screening strategies for cervical cancer and cervical intraepithelial neoplasia. Cancer 47: 1176-1181, 1981.
24. Schiffman, M. H., Bauer, H. M., Hoover, R. N., Glass, A. G., Cadell, D. M., Rush, B. B., Scott, D. R., Sherman, M. E., Kurman, R. J., Wacholder, S., Stantom, C. K. & Manos, M. M.: Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 85: 958-964, 1993.
25. Sebbelov, A. M., Svendsen, C., Jensen, H., Kjær, S. K. & Norrild, B.: Prevalence of HPV in premalignant and malignant cervical lesions in Greenland and Denmark: PCR and in situ hybridization analysis on archival material. Res. Virol. 145: 83-92, 1994.
26. Shibata, D. K.: The polymerase chain reaction and the molecular genetic analysis of tissue biopsies. In: Herrington, C. S. & McGee, J. O'D. (Eds.): Diagnostic molecular pathology. A practical approach, Vol. II. IRL Press 1992, pp. 85-111.
27. Syrjänen, K. J.: Epidemiology of human papillomavirus infections and their associations with genital squamous cell cancer. APMIS 97: 957-970, 1989.
28. Zack, J. A., Arrigo, S. J., Weitsman, S. R., Go, A. S., Haislip, A. & Chen, I. S.: HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure. Cell 61: 213-222, 1990.
29. Zur Hausen, H.: Human genital cancer: Synergism between two virus infections or synergism between a virus infection and initiating events? Lancet ii: 1370-1372, 1982.
30. zur Hansen, H.: Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184: 9-13, 1991.
31. Östör, A. G.: Natural history of cervical intraepithelial neoplasia: A critical review. Int. J. Gynecol. Pathol. 12: 186-192, 1993.